BFSG LLC
GILD icon

BFSG LLC’s Gilead Sciences GILD Stock Holding History

BFSG LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$149K Buy
1,003
+72
+8% +$10.1K 0.01% 332
2026
Q2 		$118K Buy
931
+62
+7% +$8.17K 0.01% 350
2026
Q1 		$121K Sell
869
-86
-9% -$12K 0.01% 337
2025
Q4 		$117K Buy
955
+5
+0.5% +$608 0.01% 323
2025
Q3 		$105K Buy
950
+9
+1% +$1.02K 0.01% 334
2025
Q2 		$104K Sell
941
-25
-3% -$2.66K 0.01% 319
2025
Q1 		$108K Sell
966
-1,742
-64% -$180K 0.01% 302
2024
Q4 		$250K Sell
2,708
-1,617
-37% -$146K 0.03% 215
2024
Q3 		$363K Sell
4,325
-275
-6% -$21K 0.04% 194
2024
Q2 		$316K Buy
4,600
+198
+4% +$13.2K 0.04% 196
2024
Q1 		$322K Buy
4,402
+27
+0.6% +$2.08K 0.04% 190
2023
Q4 		$354K Sell
4,375
-115
-3% -$8.95K 0.05% 185
2023
Q3 		$336K Buy
+4,490
New +$345K 0.05% 186
2022
Q3 		– Sell
-6,578
Closed -$407K – 183
2022
Q2 		$407K Buy
+6,578
New +$407K 0.07% 161
2021
Q4 		– Sell
-2,933
Closed -$202K – 224
2021
Q3 		$205K Buy
+2,933
New +$206K 0.03% 206
2020
Q3 		– Sell
-37,954
Closed -$2.92M – 193
2020
Q2 		$2.92M Sell
37,954
-645
-2% -$49.4K 0.63% 50
2020
Q1 		$2.89M Sell
38,599
-5,495
-12% -$380K 0.74% 46
2019
Q4 		$2.86M Buy
44,094
+2,340
+6% +$152K 0.54% 63
2019
Q3 		$2.57M Buy
+41,754
New +$2.73M 0.57% 60
2018
Q3 		– Sell
-5,565
Closed -$394K – 128
2018
Q2 		$394K Hold
5,565
– – 0.17% 112
2018
Q1 		$420K Sell
5,565
-615
-10% -$48.9K 0.19% 84
2017
Q4 		$443K Sell
6,180
-2,245
-27% -$170K 0.19% 86
2017
Q3 		$683K Sell
8,425
-160
-2% -$12.2K 0.31% 74
2017
Q2 		$608K Sell
8,585
-1,434
-14% -$95.4K 0.3% 73
2017
Q1 		$681K Buy
+10,019
New +$705K 0.34% 74

Other funds holding GILD

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

BFSG LLC's GILD Position: Q3 2026 in Review

BFSG LLC increased its Gilead Sciences (GILD) stake by 7.7% in Q3 2026, buying an estimated $10.1K and bringing the position to 1,003 shares worth $149K. The position accounts for 0.01% of the portfolio, ranked #332.

BFSG LLC first reported a position in GILD in Q1 2017 and has held it in 25 quarters since. The position peaked at $2.92M in Q2 2020. 2,060 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • BFSG LLC held 1,003 shares of Gilead Sciences worth $149K as of Q3 2026.
  • BFSG LLC bought 72 Gilead Sciences shares in Q3 2026, an estimated $10.1K.
  • Gilead Sciences made up 0.01% of BFSG LLC's portfolio in Q3 2026, its #332 holding.
  • BFSG LLC first reported a position in Gilead Sciences in Q1 2017 and has held it in 25 quarters since.
  • BFSG LLC's Gilead Sciences position peaked at $2.92M in Q2 2020.
  • 2,060 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on BFSG LLC's 13F filing for Q3 2026, filed 30 Oct 2026.